HEALTHY CONTROLS

This early study tests a new, personalized brain stimulation method (tACS) for depression during pregnancy. Ten women (5 with depression and 5 healthy) will receive the treatment to see if it is safe, tolerable, and practical. The goal is to gather initial data to guide larger fu…

This study tested how reliably a new radioactive tracer, [18F]-FTC-146, shows up in brain scans of healthy people. Five volunteers received the tracer on two separate days to see if the results were consistent. The goal was to understand the tracer's stability, not to treat any c…

This study tests very low, single doses of psilocybin—the active compound in magic mushrooms—in healthy adults to find a dose that is safe and does not cause psychedelic effects like hallucinations or altered consciousness. Participants receive either a low dose of psilocybin (ra…

This completed study tested whether a one-and-a-half-hour lecture on moral reasoning could improve how people justify moral decisions. 86 healthy university students were split into two groups: one received the moral reasoning lecture, the other a lecture on logical reasoning. Re…

This completed study measured levels of certain brain chemicals (glutamate, nitric oxide, and L-arginine) in 40 children—some with specific learning disorder and some without. Researchers also gave neuropsychological tests to see if chemical levels relate to learning and thinking…

This completed Phase 1 study involved 16 healthy men aged 20-35 to test a radioactive tracer called [11C]Yohimbine. Researchers used PET scans to see how the tracer binds to certain brain receptors and measured its effects after giving the drug clonidine. The goal was to understa…